Search

Your search keyword '"FLAMINI, G."' showing total 446 results

Search Constraints

Start Over You searched for: Author "FLAMINI, G." Remove constraint Author: "FLAMINI, G."
446 results on '"FLAMINI, G."'

Search Results

401. Acaricidal activity of pine essential oils and their main components against Tyrophagus putrescentiae, a stored food mite.

402. Differences in the fragrances of pollen and different floral parts of male and female flowers of Laurus nobilis.

403. Main agronomic-productive characteristics of two ecotypes of Rosmarinus officinalis L. and chemical composition of their essential oils.

404. Three anthrones from Rubus ulmifolius.

405. Chemical composition of some traditional herbal drug preparations: essential oil and aromatic water of costmary (Balsamita suaveolens Pers.).

406. A flavonoid sulphate and other compounds from the roots of Centaurea bracteata.

407. Volatile compounds from three cultivars of Olea europaea from Italy.

408. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.

409. In vitro and in vivo efficacy of extracts of Artemisia verlotorum against Psoroptes cuniculi.

410. Two flavonoids and other compounds from the aerial parts of Centaurea bracteata from Italy.

411. Evaluation of 8-hydroxydeoxyguanosine in human oral cells: the importance of tobacco smoke and urban environment.

412. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.

413. 8-hydroxy-2'-deoxyguanosine in cervical cells: correlation with grade of dysplasia and human papillomavirus infection.

414. Polycyclic aromatic hydrocarbon-DNA adducts in cervical smears of smokers and nonsmokers.

415. Analysis of 4-ABP-DNA adducts and p53 alterations in urinary bladder carcinoma.

416. Antimicrobial activity of the essential oil of Calamintha nepeta and its constituent pulegone against bacteria and fungi.

417. Biological characterization of central and peripheral primary non small cell lung cancers (NSCLC).

418. Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay.

419. Abnormalities in cell cycle control in cancer and their clinical implications.

420. P-170 Glycoprotein (MDR) and p53 Expression in Breast Cancer.

421. 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study.

422. Immunohistochemical analysis of 4-aminobiphenyl-DNA adducts in oral mucosal cells of smokers and nonsmokers.

423. Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcoma.

424. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces.

425. New prognostic factors in oncology.

426. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.

427. Expression of alpha 3 beta 1 integrin receptor and its ligands in human lung tumors.

428. Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.

429. Acaricidal agents of natural origin against Psoroptes cuniculi.

430. Flavonoids and a saponin from Spartium junceum.

431. Composition and antimicrobial properties of essential oils of four Mediterranean Lamiaceae.

432. Vasoconstrictor activity of 8-O-acetylharpagide from Ajuga reptans.

433. Idiotypic replica of an anti-human tumour-associated antigen monoclonal antibody. DNA sequence comparison between Ab1 and Ab3.

434. Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations.

436. Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.

438. Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis.

440. Immunochemical and ultrastructural study of multiple myeloma with a heavy chain protein in the serum.

441. [Rubella seroepidemiology. proposal of a predictive mathmatical model (author's transl)].

442. When is there a full recovery for a myasthenia gravis patient?

443. Non-Hodgkin lymphoma associated with double monoclonal immunoglobulin.

444. [Early diagnosis of sepsis in the preterm neonate].

445. [Supportive parenteral nutrition in surgical patients at risk. Prognostic findings in 80 cases].

446. Waldenström's macroglobulinemia and myasthenia gravis.

Catalog

Books, media, physical & digital resources